Objective This manuscript aims to provide a comprehensive review of the current knowledge
in the pathophysiology, diagnosis, prevention, and other relevant forensic and clinical …

Purpose The prevention and early diagnosis of medication-related osteonecrosis of the jaw
(MRONJ) is fundamental to reducing the incidence and progression of MRONJ. Many in the …

Tooth extraction is a risk factor for the development of osteonecrosis of the jaw following
treatment with antiresorptive drugs (ARDs), but not all extraction sites develop this …

Objective: Patients with medication-related osteonecrosis of the jaw (MRONJ) often visit their
dentists at advanced stages and subsequently require treatments that greatly affect quality of …

Purpose This systematic review was performed to assess the potential influence of
medication-induced salivary changes on the development of medication-related …

Objectives To identify clinical and local radiographic predictors for medication-related
osteonecrosis of the jaws (MRONJ) by the assessment of pre-operative CBCT images of …

Background Medication‐related osteonecrosis of the jaw (MRONJ) is clinically defined as a
non‐healing jawbone ulcerative‐necrotic lesion appearing after dental therapy or minor …

Objective To identify local radiographic risk factors for Medication‐Related Osteonecrosis of
the Jaws (MRONJ) in osteoporotic patients treated with antiresorptive drugs (ARD) and …

Objectives To compare the diagnostic accuracy in detecting early non‐vital bone changes
between orthopantomography (OPT) and cone‐beam computed tomography (CBCT) in …

Objectives Medication‐related osteonecrosis of the jaw (MRONJ) is a severe adverse effect
of antiresorptive and/or antiangiogenic agents. As the treatment application for MRONJ is …